BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 12432185)

  • 21. Diagnosis of acute pancreatitis.
    Kemppainen E; Puolakkainen P; Leppäniemi A; Hietaranta A; Grönroos J; Haapiainen R
    Ann Chir Gynaecol; 1998; 87(3):191-4. PubMed ID: 9825062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical laboratory assessment of acute pancreatitis.
    Al-Bahrani AZ; Ammori BJ
    Clin Chim Acta; 2005 Dec; 362(1-2):26-48. PubMed ID: 16024009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
    Gottlieb K; Sherman S; Pezzi J; Esber E; Lehman GA
    Am J Gastroenterol; 1996 Aug; 91(8):1553-7. PubMed ID: 8759660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical evaluation of laboratory tests in acute pancreatitis.
    Yadav D; Agarwal N; Pitchumoni CS
    Am J Gastroenterol; 2002 Jun; 97(6):1309-18. PubMed ID: 12094843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
    Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
    Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis.
    Kemppainen EA; Hedström JI; Puolakkainen PA; Sainio VS; Haapiainen RK; Perhoniemi V; Osman S; Kivilaakso EO; Stenman UH
    N Engl J Med; 1997 Jun; 336(25):1788-93. PubMed ID: 9187069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.
    Testoni PA
    JOP; 2002 Nov; 3(6):195-201. PubMed ID: 12432186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unresolved issues about post-ERCP pancreatitis: an overview.
    Testoni PA
    JOP; 2002 Nov; 3(6):156-61. PubMed ID: 12432181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip.
    Kylänpää-Bäck M; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Perhoniemi V; Kivilaakso E; Korvuo A; Stenman U
    Br J Surg; 2000 Jan; 87(1):49-52. PubMed ID: 10606910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting and preventing post-ERCP pancreatitis.
    Baillie J
    Curr Gastroenterol Rep; 2002 Apr; 4(2):112-9. PubMed ID: 11900675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
    Conn M; Goldenberg A; Concepcion L; Mandeli J
    Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
    Doppl WE; Weber HP; Temme H; Klör HU; Federlin K
    Eur J Med Res; 1996 Mar; 1(6):303-11. PubMed ID: 9367944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
    Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Korvuo A; Stenman UH
    Hepatogastroenterology; 2002; 49(46):1130-4. PubMed ID: 12143219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of urine trypsinogen-2 test in the differential diagnosis of acute pancreatitis in the Emergency Department.
    Cevik Y; Kavalci C; Ozer M; Daş M; Kiyak G; Ozdoğan M
    Ulus Travma Acil Cerrahi Derg; 2010 Mar; 16(2):125-9. PubMed ID: 20517765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prediction and monitoring of severe acute pancreatitis].
    Gürlich R; Maruna P; Spicák J
    Cas Lek Cesk; 2006; 145(6):437-41; discussion 442. PubMed ID: 16835994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.